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ABSTRACT
Long chain omega-3 polyunsaturated fatty acids (LC n-3 PUFA) are beneficial for health.
To date there is no specific food frequency questionnaire (FFQ) to assess LC n-3 PUFA
intakes. The objective of this study is to validate our newly developed FFQ by comparison
with LC n-3 PUFA content of both red blood cells (RBC) and plasma, expressed as a
percentage of total fatty acids. Fifty-three healthy male and female subjects were recruited
from Wollongong, Australia. Average LC n-3 PUFA intakes (mg/day) were estimated using
the new FFQ. RBC and plasma fatty acids were assessed using gas chromatography.
Spearman correlation co-efficients assessed the linear relationship between FFQ intakes and
both RBC and plasma fatty acids. ) The results show that there were significant Spearman’s
correlation co-efficients between the FFQ intakes and RBC (and plasma) fatty acids for total
LC n-3 PUFAs, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (0.50 (0.54),
0.39 (0.54) and 0.40 (0.48) respectively) but not for docosapentaenoic acid (DPA). The FFQ
was also an effective ranking tool. In summary, the FFQ is a valid method based on
erythrocyte and plasma fatty acids as biochemical markers. In conclusion, the new FFQ is a
valid method that can be used to estimate the LC n-3 PUFA intake of adults.
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INTRODUCTION
The various health benefits of consuming the long chain n-3 polyunsaturated fatty acids (LC
n-3 PUFA), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA),
have been reported widely (1-6). The LC n-3 PUFA are obtained predominately from fish,
seafood, meat and eggs (7, 8) and in recent years from enriched food products such as bread,
milk, margarine and eggs. Recommendations for dietary intakes of LC n-3 PUFA vary
considerably from the consumption of two fish meals a week (9) to EPA plus DHA intakes
of 500mg/day (10) and the Japanese recommend consumption of LC n-3 PUFA of 1.6g/day
(11).
Currently there is no tailor made food frequency questionnaire (FFQ) to assess LC n-3 PUFA
intakes. We have developed a new FFQ that estimates the dietary intakes of LC n-3 PUFA.
The FFQ was found to be highly reproducible and valid compared to 3-day weighed food
records in 53 healthy adults (12). However, as biochemical measurements of specific
nutrients in the blood or other tissues can also provide useful assessments of nutrient intake
(13), it is desirable to validate the FFQ further using biomarkers of LC n-3 PUFA intake.
There are several choices of a biomarker for the measurement of LC n-3 PUFA including
fatty acids in adipose tissue (14), red blood cells (RBCs), platelets, plasma, cholesterol
esters, phospholipids (13) and potentially cheek cells (15). RBCs may be a useful marker as
they can provide an indication of the previous 120 days intake of LC n-3 PUFA, the
approximate lifespan of a RBC (16). RBCs were found to be a good biomarker of LC n-3
PUFA intake as EPA and DHA were incorporated into RBCs according to dose (17). Plasma
has also been found to reflect LC n-3 PUFA intake in various studies (18, 19).
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The aims of this study were to 1) compare estimates of dietary LC n-3 PUFA intakes using
the new FFQ to previously published results; 2) compare estimates of dietary LC n-3 PUFA
intakes using the new FFQ to RBC fatty acids; 3) compare estimates of dietary LC n-3
PUFA intakes to plasma fatty acids, 4) determine the efficacy of the FFQ to rank individuals




Subject Recruitment and Clinic Visits
Poster and e-mail advertisements were used to recruit staff and students from the University
of Wollongong, Australia. There were no exclusion criteria with the only requirement being
that subjects had maintained a constant diet over the previous three months. Vegetarians
were encouraged to volunteer to ensure a wide range of dietary habits among the subjects.
Based on RBC data from a previously unpublished study, it was determined that a minimum
of 50 subjects should be sufficient to detect an effect size of 1 with more than 99% power at
a significance level of 0.05, assuming that the correlation between methods is 0.6. The effect
size is the difference between the means of the two methods, divided by the standard
deviation (SD) of either method.
Subjects attended a single clinic appointment and came in after an overnight fast to provide a
fasted blood sample for RBC and plasma fatty acid analysis. Digital scales and a wall-
mounted stadiometer were used to measure weights and heights, respectively. Subjects then
completed the FFQ. Approval to conduct the study was obtained from the University of
Wollongong Human Research Ethics Committee and subjects gave their written consent.
LC n-3 PUFA Food Frequency Questionnaire and Determination of Intakes
The 28 item semi-quantitative FFQ consists of a list of food items that are currently the only
major contributors to LC n-3 PUFA intake, and is available from BM. The foods included in
the 28 questions are from the following food groups: fish and seafood (6 questions), meats
(12), cereals (4), fat spreads (2), dairy (2), eggs (2) including LC n-3 PUFA fortified
products such as breads, milks, margarines and eggs. Fish oil capsules are also included in
the questionnaire. The FFQ also asks the subject to estimate ususal meat serve size in terms
of pictures of meat on a plate. The dietary validation of this FFQ has been published
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elsewhere (12). The FFQ was self-administered by subjects and took approximately 15
minutes to complete. The LC n-3 PUFA intakes of FFQ and the 3 day weighed Food
Record (FR) were determined as described by Sullivan et al. (12).
Comparison to other published intakes
To determine if the FFQ is measuring a plausible intake, another dietary intake comparator
was necessary. Therefore, the intakes estimated using the FFQ were compared with those of
a larger Australian sample using a 24 hour recall method taken from the 1995 National
Nutrition Survey (NNS) to estimate LC n-3 PUFA intake (20). The NNS collected data from
10,591 Australians aged 19 years and older, but at a time when omega-3 fortified foods were
not on the market. The Wilcoxon signed rank test was used to compare the FFQ data
(without the inclusion of fortified foods or fish oil capsules) to the 3 day weighed food
record (FR) (as previously described (12)) with comparison to the NNS data (21).
Blood collection, preparation and analysis of RBCs and plasma fatty acids
Blood was collected into tubes containing ethylenediamine tetra-acetic acid (EDTA) and
placed on ice. The samples were separated by centrifugation (10 min, 3000rpm, 4°C). The
plasma was separated from the sample into labelled eppendorf tubes. The white buffy layer
was removed and discarded and the remaining RBCs were transferred into labelled
eppendorf tubes. RBC and plasma samples were stored at -80°C until analysed.
RBC membranes were prepared for fatty acid analysis as described by Ridges et al. (22).
The total volume of the resuspended pellets was transferred into glass tubes for direct
transesterification as described by Lepage and Roy (23). Briefly, 2ml of methanol: toluene
(4:1) was added to each sample. While vortexing, 200µl of acetyl chloride was added drop
wise to each sample using a positive displacement pipette. Samples were then heated for 60
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minutes at 100°C in a heating block. After the tubes had been cooled in cold water, 3ml of
potassium chloride (10%) and 100µl of toluene were added to each tube before
centrifugation for 10 minutes (3000rpm, 4°C). The fatty acid methyl esters, contained in the
upper toluene phase, were removed and placed into GC vials. The fatty acid methyl esters
were analysed by flame-ionisation gas chromatography (model GC-17A, Shimadzu) using a
30m x 0.25mm internal diameter capillary column. Individual fatty acids were identified
upon comparison with known fatty acid standards (Supelco F.A.M.E. mix C4-C24 (plus
added DPA), #18919-1AMP, Sigma, Australia).
Total plasma fatty acids were determined using the method by Lepage and Roy (23).
Aliquots of 200µl of plasma were transferred into glass tubes for direct transesterification
(23) and as briefly described above, however instead of using 3ml potassium chloride (10%),
5ml potassium chloride (5%) was used and instead of adding 100µl toluene, no toluene was
added. Fatty acid methyl esters were analysed as described above.
Comparison of FFQ and LCn-3 PUFA content of RBCs and plasma
Means (SD) were calculated for the total LCn-3 PUFA, EPA, docosapentaenoic acid (DPA)
and DHA content (as a percentage of total fatty acids) of the RBCs and plasma. Spearman’s
correlation coefficients were determined for the relationship between FFQ estimated daily
intakes and LCn-3 PUFA content of both RBCs and plasma.
Quintile agreement
Subjects were ranked in ascending order of their daily total intake of LC n-3 PUFA
estimated from the FFQ and both RBC and plasma fatty acids. They were then separated
into quintiles. Quintiles were determined by assessing the actual intakes from 53 subjects
ranging from 0 to 1100mg/day and then dividing the subjects into 5 equal groups, where
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quintile 1 equals 0-98mg/d, quintile 2 equals 99-188mg/d, quintile 3 equals 189-304mg/d,
quintile 4 equals 305-449mg/d and quintile 5 equals 450-1100mg/d. The percentage
agreement was determined between the quintile assignments using the FFQ and RBC fatty
acids and separately for the FFQ and plasma fatty acids.
Statistical Analysis
Means (SD) were calculated for the total LCn-3 PUFA, EPA, DPA and DHA content (as a
percentage of total fatty acids) of the RBCs and plasma. The relationships between FFQ
estimated daily intakes and LCn-3 PUFA content of both RBCs and plasma were assessed by
Spearman’s correlation coefficients.
Quintile agreement was assessed by determining the percentage agreement between quintile
assignments using the FFQ and RBC fatty acids and for FFQ and plasma fatty acids.
Statistical analysis was performed using JMP statistical analysis program (Version 5.1, SAS
Institute, Cary, NC, USA). Statistical significance was set at α = 0.05 for all analyses.
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RESULTS
Fifty-three subjects (20 male and 33 female) were recruited for the validity study, including
seven self-reported vegetarians. Two vegetarians were vegans, one ate extremely small
amounts of fish and two individuals were lactoovovegetarians. The remaining two reported
eating significant amounts of fish in the FFQ. The subject characteristics are presented in
Table 1.
Comparison of our FFQ LC n-3 PUFA intakes to the National Nutrition Survey (NNS) of
Australia
Table 2 shows the LC n-3 PUFA intakes data estimated from the FFQ (excluding fortified
foods and fish oil capsules) in comparison to the analysis of the National Nutrition Survey
(NNS) of Australia conducted by Howe et al. (20). There were no significant differences
between the estimates in this study using the FFQ and the NNS data.
Comparison of our LC n-3 PUFA FFQ to the Fatty Acid Content of RBCs and plasma
Comparison of the LC n-3 PUFA intakes estimated from the FFQ to the percentage of the
total fatty acid content of RBCs and plasma are shown in Table 3.
Bivariate plots of the FFQ estimation of LC n-3 PUFA intakes and percentage of total fatty
acid content of the RBCs showed that there were good, significant relationships for total LC
n-3 PUFAs, EPA, and DHA (Figures 1a, 1b and 1d). There was no apparent relationship for
DPA (Figure 1c). Similar patterns were observed for the relationship between the FFQ
estimated intakes and LC n-3 PUFA content of plasma. As seen with the RBCs, there was
no relationship between FFQ estimation of DPA intakes and the content of plasma as
indicated by the non-significant Spearman’s correlation of 0.09.
11
The efficacy of the FFQ to rank individuals into quintiles of intakes of LC n-3 PUFA
Subjects were also assigned quintiles based on total LC n-3 PUFA content of the RBCs (%
of total fatty acids) (Table 4). Forty percent of subjects were correctly assigned into the
same quintiles while 75% of subjects were assigned to either the same or adjacent quintile.
The FFQ was most successful at identifying individuals with very low intakes. Similar
results were obtained for agreement of quintile assignment between FFQ total LC n-3 PUFA
intakes and total LC n-3 PUFA content of plasma (Table 4). Five out of the seven vegetarian
subjects were found in the first quintile for both analyses.
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DISCUSSION
Our new FFQ estimates the dietary intakes of LC n-3 PUFA very well as the results compare
favourably to the results from the NNS of Australia (Table 2, and ref. 20). The NNS intakes
of EPA and DPA were slightly higher and the NNS intakes of DHA were slightly lower than
our study, which could be explained by the fact that our study group contained 7 vegetarians.
With meat being a rich source of DPA (24), the inclusion of 7 vegetarian subjects (who did
not eat meat) in this study may account for the lower DPA intakes.
Other studies have used various biomarkers to validate newly developed or existing FFQs,
although not many have been validated for LC n-3 PUFA intake and those that do use
biomarkers other than RBCs. Woods et al. (25) validated an existing semi-quantitative FFQ
for measuring fish intake with plasma fatty acid composition. That FFQ was assessing
overall dietary intake over the preceding 12 months and was originally developed for use by
the Anti Cancer Council of Victoria. Significant Pearson correlation co-efficients were
obtained between percentage of plasma fatty acids and grams of steamed, grilled or baked
fish and grams of total non-fried fish consumed (r = 0.33 for DHA and 0.34 for total LC n-3
PUFA). Significant Pearson correlation co-efficients were also obtained between the
percentage of total plasma n-3 PUFAs and the same two variables which were both found to
be 0.33. Our FFQ shows higher Spearmans correlation co-efficients (r=0.50 for total LC n3
PUFA, r=0.39 for EPA and r=0.40 for DHA), hence our newly developed FFQ is an
improvement on previously validated FFQs to estimate LC n-3 PUFA intakes (25).
There are a few reasons why our new FFQ shows higher correlations. Firstly, in Woods et
al. (25), intakes of fish (steamed, baked, grilled, fried and takeaway fish) and tinned fish
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were calculated without the inclusion of other types of seafood. There was no distinction
between different fish species which are known to have large variations in LC n-3 PUFA
content (24). Secondly, other foods that contain LC n-3 PUFAs were not included in the
analysis such as eggs and meat (8) and these may account for nearly 50% of LC n-3 PUFA
intakes (20). Finally, a major limitation was that at the time of the study there was no
Australian database for the estimation of DHA and EPA intakes from the FFQ, which has
now been rectified by Mann et al. (26).
Our correlation co-efficients between RBC and dietary intakes of LC n-3 PUFA compare
favourably to the study by Anderson et al. (18). Correlation coefficients between plasma
phospholipid fatty acids and dietary intakes of EPA and DHA were 0.51 and 0.49,
respectively. Their correlation between fish intake and n-3 PUFA in plasma phospholipids
was 0.37 whilst our correlation co-efficient of total intake of LC n-3 PUFA and RBC LC n-3
PUFA was 0.5. Their lower correlation between fish intake and n-3 PUFA in plasma
phospholipids further highlights the fact that foods other than fish and seafood contribute to
LC n-3 PUFA intake (20).
The mean percentages of LC n-3 PUFAs in RBCs in our study were comparable to those
determined in other studies (17, 26). LC n-3 PUFA content of plasma was however lower
than reported in other studies (25, 27). RBCs and plasma were found to be good biomarkers
of total LC n-3 PUFA, EPA and DHA intakes as highlighted by the significant Spearman’s
correlation co-efficients but RBC and plasma were not found to be good biomarkers of DPA
intakes (r=0.05). Significant correlations between dietary intakes and RBC fatty acids were
expected for EPA and DHA as both fatty acids have been found to be incorporated into
RBCs by dose (17). However, DPA intakes estimated from the FFQ were found to be highly
reproducible with a highly significant Spearman correlation co-efficient of 0.89 (12). This
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evidence strongly suggests that the lack of correlation is not due to the FFQ instrument itself
and that it is more likely due to biological or metabolic factors and this warrants further
investigation.
Quintile assignment proved that the FFQ was able to adequately identify individuals
according to their RBC levels of LC n-3 PUFA. Five out of the seven vegetarians were
correctly assigned to the first (lowest intake) quintile based on intakes measured by the FFQ
and LC n-3 content of the RBCs. Agren et al. (28) also found that Finnish vegans had
significantly lower EPA, DPA and DHA in their RBCs than omnivorous subjects. The other
two self-reported vegetarians, as expected, had higher LC n-3 PUFA content of RBCs due to
significant intakes of fish and seafood. Overall, the quintile assignment in this study was
better than or consistent with other studies. The FFQ used by Erkkola et al. (29) classified
62% of individuals into the same or adjacent quintiles based on total n-3 PUFA intakes. The
ability of this FFQ to classify more than 75% of individuals into identical or adjacent
quintiles may be useful in clinical settings to identify individuals with low LC n-3 PUFA
status.
In summary, the FFQ performed well against the RBC membrane and total plasma fatty
acids, apart from the lack of correlation between DPA intakes and DPA content of both
RBCs and plasma, suggesting that these may not be good biomarkers of DPA intake. The
FFQ is therefore an adequate dietary assessment tool for the estimation of total LC n-3
intakes in healthy Australian adults and would be a useful screening tool for low intakes of
LC n-3 PUFAs. It is an appealing alternative to other dietary assessment methods due to its
validity, low subject burden and low cost and being very fast to complete. In conclusion, the
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TABLES




Age (years) 34.6 (11.6) 19-58
Height (cm) 168.5 (10.0) 145-187
Weight (Kg) 68.4 (13.4) 43-100
BMI (Kg/m2) * 23.9 (3.1) 18.7-33.0
*BMI= body mass index
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Table 2. Average daily intakes (mg/day) of the individual and total LC n-3 PUFAs

























*expressed as mean (SD)
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a expressed as % of total fatty acids
b significant at p< 0.001
c significant at p< 0.01
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Table 4. Agreement of quintile assignment between FFQ total LC n-3 PUFA intakes
and total LC n-3 PUFA content of both RBCs and plasma (n = 53).













1 (n= 10) 8 1 1 7 2 1
2 (n= 11) 2 5 4 2 5 4
3 (n= 11) 5 5 1 3 6 2
4 (n= 11) 3 4 4 1 8 2
5 (n= 10) 3 4 3 2 5 3
Total no. (%) 21 (40) 19 (36) 13 (24) 15 (28) 26 (49) 12 (23)
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Figures
Figure 1a. The relationship between estimated total LCn-3 PUFA intake from the FFQ and
the LCn-3 PUFA content of the RBCs with calculated Spearman correlation co-efficient.
r=0.50
(p<0.001)
Figure 1b. Bivariate plot of EPA intakes estimated by the FFQ versus the EPA content of
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Figure 1c. Bivariate plot of DPA intakes estimated by the FFQ versus the DPA content of
the RBCs as a percentage of total fatty acids with calculated Spearman correlation co-
efficient. line of best fit was not fitted to this plot due to the obvious lack of relationship
between the two measurements.
r = 0.05
(p = 0.71)
Figure 1d. Bivariate plot of DHA intakes estimated by the FFQ versus the DHA content of
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Table 3. Intake of total LC n-3 PUFAs, EPA, DPA and DHA estimated from FFQ and
measured from 3-day FR in mg/day (n=45).
FFQ (mg/day) FR (mg/day)FATTY
ACID





Total LC n-3 259 (209) 212 264 (222) 234 0.822
EPA 73 (63) 58 75 (71) 65 0.670
DPA 52 (41) 48 49 (38) 40 0.487
DHA 134 (120) 108 141 (142) 125 0.391
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